These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10879224

  • 1. Usefulness and limitations of an in-house direct radioimmunoassay for 17-hydroxyprogesterone in serum.
    Lo MS, Ng ML, Wu LL, Azmy BS, Khalid BA.
    Malays J Pathol; 1996 Jun; 18(1):43-52. PubMed ID: 10879224
    [Abstract] [Full Text] [Related]

  • 2. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS, Ng ML, Wu LL, Khalid BA.
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]

  • 5. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Jan; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 6. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 7. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov 09; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 10. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan 09; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 11. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005 Jan 09; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 12. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
    Mitchell ML, Hermos RJ.
    Clin Endocrinol (Oxf); 1998 Jun 09; 48(6):757-60. PubMed ID: 9713565
    [Abstract] [Full Text] [Related]

  • 13. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb 09; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 14. An enzyme immunoassay for determining 17alpha-hydroxyprogesterone in dried blood spots on filter paper using an ultramicroanalytical system.
    González EC, Marrero N, Pérez PL, Frómeta A, Zulueta O, Herrera D, Martínez L, Castells E.
    Clin Chim Acta; 2008 Aug 09; 394(1-2):63-6. PubMed ID: 18442476
    [Abstract] [Full Text] [Related]

  • 15. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan 09; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 16. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.
    J Perinat Med; 2014 Jan 09; 42(1):121-7. PubMed ID: 23989111
    [Abstract] [Full Text] [Related]

  • 17. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q, Wang B, Chen Y, Jiang D, Chen Y.
    Zhonghua Er Ke Za Zhi; 2014 Sep 09; 52(9):706-9. PubMed ID: 25476436
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia.
    Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D.
    Ann Clin Biochem; 1987 Jan 09; 24 ( Pt 1)():58-65. PubMed ID: 3827186
    [Abstract] [Full Text] [Related]

  • 19. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ, Goossens K, Setyawati BA, Drop SL, de Jong FH, Faradz SM.
    Singapore Med J; 2011 Nov 09; 52(11):810-3. PubMed ID: 22173250
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two different radioimmunoassays to measure 17-hydroxyprogesterone during treatment monitoring of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C, Böhles H, Maser-Gluth C.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):186-9. PubMed ID: 20933513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.